Immune mechanisms of lung allograft rejection.

Published

Journal Article (Review)

Extended survival after lung transplantation is primarily limited by progressive airflow obstruction and fibrotic obliteration of the small airways, termed bronchiolitis obliterans syndrome (BOS) and bronchiolitis obliterans (BO), respectively. BO is thought to represent the pulmonary-specific manifestation of chronic allograft rejection and the end result of a spectrum of different immunological insults to the allograft. Historically, research has focused on the adaptive immune system and its cellular-based rejection as the driving factor in the development of BO. Recent research in animal lung transplant models and human lung transplant recipients has identified that chemokines, humoral immunity, autoimmunity, and innate immunity also contribute to lung allograft rejection and BO. This review explores the complex immunological mechanisms that promote the high rate of pulmonary allograft failure and significantly impair survival after lung transplantation. We also identify areas for further research critical to improving transplant outcomes.

Full Text

Duke Authors

Cited Authors

  • Snyder, LD; Palmer, SM

Published Date

  • October 2006

Published In

Volume / Issue

  • 27 / 5

Start / End Page

  • 534 - 543

PubMed ID

  • 17072801

Pubmed Central ID

  • 17072801

International Standard Serial Number (ISSN)

  • 1069-3424

Digital Object Identifier (DOI)

  • 10.1055/s-2006-954610

Language

  • eng

Conference Location

  • United States